Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Purec, a Japan-based regenerative medicine spinout of Shimane University, secured ¥300m ($2.7m) in funding on Wednesday from photography and imaging company Fujifilm. Purec is working on a treatment for osteogenesis imperfecta, a group of genetic disorders that causes fragile bones that break even from mild trauma or without apparent impact. The investment will enable Fujifilm’s parent company, regenerative medicine producer Japan Tissue Engineering (J-Tec), to tap into the spinout’s technology. Purec and J-Tec will collaborate on the development of products.
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
